Trial Profile
A Phase 1, Open Label, Fixed Sequence Design, Multiple Dose Study To Assess The Effect Of Rifampin On The Pharmacokinetics Of Sitaxsentan In Healthy Subjects.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I
Latest Information Update: 13 Mar 2015
Price :
$35
*
At a glance
- Drugs Sitaxentan (Primary) ; Rifampicin
- Indications Tuberculosis
- Focus Pharmacokinetics
- 21 Dec 2010 New trial record